Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc

Aquestive Therapeutics Inc Price Chart AQST

Historical daily share price chart and data for Aquestive Therapeutics Inc since 2018 adjusted for splits and dividends. The latest closing price for Aquestive Therapeutics Inc as of November 21, 2019 is $6.2.
  • In 2019 the stock opened at $6.09 and closed at $6.20 for a gain of 2% YTD.
  • In 2018 the stock opened at $15.05 and closed at $6.30 for a loss of -139%.
View Chart On Koyfin

Aquestive Therapeutics Inc Summary

Stock Symbol: AQST

Aquestive Therapeutics Inc Company Info

Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery in the United States and internationally. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The company's proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly and neuroendocrine tumors. It also develops AQST-119, an oral soluble film formulation of tadalafil for the treatment of erectile dysfunction; and APL-130277, a sublingual film using apomorphine to treat parkinson’s disease. Aquestive Therapeutics, Inc. was founded in 2004 and is headquartered in Warren, New Jersey.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
38.31 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of AQST Prices